“…The presence of hemosiderin in the skin has been described in numerous disorders, as discussed in a textbook of Dermatopathology: stasis dermatitis, Schamberg's disease (pigmented purpuric dermatosis), hemochromatosis, hemosiderosis, secondary to Monsel's solution application, secondary to iron sesquioxide application, Zoon's balanitis/vulvitis, atrophie blanche, erythema ab igne, traumatic fat necrosis, scurvy, antiphospholipid syndrome, pigmented pretibial patches, secondary to earrings, around glass fragments, dermatofibroma, juvenile xanthogranuloma, papular xanthoma, progressive nodular histiocytosis, dermatofibrosarcoma protuberans, giant cell tumor, granuloma faciale, melanoma, hemosiderotic fibrohistiocytic lipomatous tumor, pleomorphic hyalinizing angiectatic tumor, plexiform fibrohistiocytic tumor, epithelioid sarcoma, neurilemmoma, apocrine adenocarcinoma, pilomatrixoma, acroangiodermatitis, Kaposi's sarcoma, angiosarcoma, targetoid hemosiderotic hemangioma and other vascular tumors. Pubmed literature review reveals additional conditions with dermal hemosiderin: ecchymoses, hemosiderotic atypical fibroxanthoma, Ehlers‐Danlos syndrome, cutaneous umbilical endometriosis, hyperthyroidism, atypical decubital fibroplasia, post leg sclerotherapy, minocycline adverse reaction and nephrogenic systemic fibrosis …”